GCTK
$1.13
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States.
Recent News
Glucotrack Announces 3 New Patents to Monitor Blood Glucose
By Karen Roman GlucoTrack, Inc. (Nasdaq: GCTK) said the U.S. Patent and Trademark Office issued three patents for its continuous blood glucose monitoring platform as the company moves toward commercializing it. The three patents protect key technologies related to proprietary sensor chemistry, intravascular lead design, and low-power electronics, the company stated. “Securing our intellectual property […]
BC-Most Active Stocks
td class="col-issue">Next Technology Holding Inc.
Wall Street Set to Open Little Changed Friday Ahead of Consumer Sentiment Report
US stocks look set to open little changed in Friday's trading session ahead of consumer sentiment da
Exchange-Traded Funds Higher, Equity Futures Mixed Ahead of September Consumer Sentiment Report
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.1% and the actively trad
Consumer Sentiment, Oil Inventory Reports Set for Release as US Futures Little Changed in Friday's Premarket Session
US stock futures were little changed in Friday's premarket session ahead of consumer sentiment and o